Your browser doesn't support javascript.
loading
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.
Voss, M H; Bastos, D A; Karlo, C A; Ajeti, A; Hakimi, A A; Feldman, D R; Hsieh, J J; Molina, A M; Patil, S; Motzer, R J.
Afiliación
  • Voss MH; Departments of Medicine. Electronic address: vossm@mskcc.org.
  • Bastos DA; Departments of Medicine.
  • Karlo CA; Radiology.
  • Ajeti A; Departments of Medicine.
  • Hakimi AA; Surgery, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, USA.
  • Feldman DR; Departments of Medicine.
  • Hsieh JJ; Departments of Medicine.
  • Molina AM; Departments of Medicine.
  • Patil S; Biostatistics and Epidemiology.
  • Motzer RJ; Departments of Medicine.
Ann Oncol ; 25(3): 663-668, 2014 Mar.
Article en En | MEDLINE | ID: mdl-24458473

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Sirolimus / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Sirolimus / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article